The present invention describes novel 1,3-dihydro-imidazol-2-one or 1,3-dihydro-imidazol-2-thione compounds of formula (I):
or a stereoisomer or pharmaceutically acceptable salt or solvate thereof, wherein A, L R
1
, R
2
, R
3
and R
4
are defined in the present specification, which are useful as selective inhibitors of MMP, TACE, aggrecanase or a combination thereof. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.
本发明描述了新颖的
1,3-二氢咪唑-2-酮或1,3-二氢
咪唑-2-
硫酮化合物,
化学式为(I):或其立体异构体或药学上可接受的盐或溶剂,其中A、L、R1、R2、R3和R4在本说明中有定义,这些化合物可用作MMP、TACE、聚集素酶或其组合的选择性
抑制剂。本发明还涉及包含这些化合物的药物组合物以及使用这些药物的方法。